Expression of Senescence Marker TIGIT Identifies Polyfunctional Donor-Reactive CD4+ T Cells Preferentially Lost After Kidney Transplantation.
Adult
Age Factors
Aged
Aging
/ genetics
Biomarkers
CD4-Positive T-Lymphocytes
/ immunology
Cell Survival
/ genetics
Female
Gene Expression
Humans
Immunophenotyping
Kidney Transplantation
Lymphocyte Depletion
Male
Middle Aged
Receptors, Immunologic
/ genetics
Tissue Donors
Transplant Recipients
Young Adult
T-cells
alloreactive
antigen-specific
kidney transplantation
senescence
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2021
2021
Historique:
received:
21
01
2021
accepted:
14
04
2021
entrez:
17
5
2021
pubmed:
18
5
2021
medline:
30
9
2021
Statut:
epublish
Résumé
Development of T-cell hyporesponsiveness to donor antigen may explain the substantial decreased risk for acute rejection in the years following kidney transplantation. The underlying mechanisms of donor-specific hyporesponsiveness (DSH) are largely unknown but may allow for lowering of immunosuppressive medication. Due to the onset of DSH being more rapid and pronounced in older recipients (+55 years), we hypothesized that immunosenescence/exhaustion of T lymphocytes would be a contributing factor. This study tested whether donor-reactive recipient T cells become hyporesponsive due to exhaustion from continuous stimulation by donor antigen. Circulating donor-reactive T cells of both young and elderly stable kidney transplant recipients (N=17) before and 3-5 years after transplantation were analyzed at the single cell level for expression of exhaustion markers by multi-parameter flow cytometry followed by unsupervised and unbiased clustering. Clusters containing cells of a particular expression profile with significant differential abundance after transplantation were identified and further analyzed. Unexpectedly, our results do not demonstrate an increase in exhausted donor antigen-reactive T cells post transplantation. Instead, we demonstrate a significant decrease in donor antigen-reactive CD4+ T cells expressing T cell immunoglobulin and ITIM domain (TIGIT) long after transplantation. Further analysis at earlier timepoints indicated that this decrease is already present at six months post transplantation. Characterization of these CD4+ T donor-reactive cells expressing TIGIT revealed them to have a predominantly central and effector memory T cell phenotype and a highly poly-functional cytokine expression profile. This study has therefore identified TIGIT as a marker for a previously undescribed polyfunctional donor-reactive CD4+ T cell population whose decline following kidney transplantation may explain development of DSH.
Identifiants
pubmed: 33995373
doi: 10.3389/fimmu.2021.656846
pmc: PMC8119878
doi:
Substances chimiques
Biomarkers
0
Receptors, Immunologic
0
TIGIT protein, human
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
656846Informations de copyright
Copyright © 2021 van der List, Litjens, Klepper and Betjes.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Clin Exp Dermatol. 2018 Aug;43(6):675-682
pubmed: 29512851
Blood. 2009 Oct 29;114(18):3947-55
pubmed: 19713464
J Transplant. 2020 Jan 29;2020:5694670
pubmed: 32099669
J Am Soc Nephrol. 2003 Jun;14(6):1652-61
pubmed: 12761268
BMJ Case Rep. 2021 Feb 8;14(2):
pubmed: 33558380
Transplantation. 2009 May 27;87(10):1451-4
pubmed: 19461480
Commun Biol. 2019 May 14;2:183
pubmed: 31098416
Clin Med (Lond). 2020 Mar;20(2):142-145
pubmed: 32188647
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Cytometry A. 2015 Jul;87(7):636-45
pubmed: 25573116
Adv Cancer Res. 2015;128:1-68
pubmed: 26216629
Oncologist. 2020 Jun;25(6):505-514
pubmed: 32043699
Am J Transplant. 2006 Dec;6(12):2955-64
pubmed: 17294523
J Nephrol. 2017 Dec;30(6):859-868
pubmed: 27686224
Nat Immunol. 2011 Jun;12(6):492-9
pubmed: 21739672
Cancers (Basel). 2019 Jun 23;11(6):
pubmed: 31234588
Transplantation. 1997 Aug 15;64(3):472-9
pubmed: 9275115
Nucleic Acids Res. 2012 May;40(10):4288-97
pubmed: 22287627
J Immunol. 2012 Apr 15;188(8):3869-75
pubmed: 22427644
Clin Exp Immunol. 2013 Oct;174(1):179-91
pubmed: 23750604
J Clin Invest. 2020 Feb 3;130(2):748-753
pubmed: 31904583
J Clin Invest. 2015 May;125(5):2046-58
pubmed: 25866972
Trends Immunol. 2017 Jan;38(1):20-28
pubmed: 27793572
J Am Soc Nephrol. 2002 Dec;13(12):2983-9
pubmed: 12444218
Ann Transplant. 2016 Feb 11;21:94-104
pubmed: 26864516
J Immunol. 2006 Jan 15;176(2):770-7
pubmed: 16393960
Sci Rep. 2018 Feb 6;8(1):2461
pubmed: 29410442
Kidney Int. 2019 Aug;96(2):436-449
pubmed: 31040060
Exp Cell Res. 2016 Jan 1;340(1):132-8
pubmed: 26683997
Immunity. 2016 May 17;44(5):989-1004
pubmed: 27192565
J Am Soc Nephrol. 2016 Nov;27(11):3299-3307
pubmed: 27020853
J Immunol. 2004 May 1;172(9):5456-66
pubmed: 15100287
Kidney Int. 1996 Sep;50(3):1019-25
pubmed: 8872979
Transplantation. 2008 Apr 27;85(8):1205-11
pubmed: 18431243